C2 and COVID-19: Among KIR/HLA-C pairs, inhibitory KIR2DL1 binds to C2 with higher affinity than KIR2DL2/3 to C1, which may account for the increased KIR2DL1 + C2 combination in mild, but not severe COVID-19 patients.